Page 2 - Sridhar Venkatesh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sridhar venkatesh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sridhar Venkatesh Today - Breaking & Trending Today

GlaxoSmithKline Pharma reports 2% YoY growth in revenue at Rs808cr

PBT (before exceptional items) from Continuing Operations for the quarter at Rs 189 crores recorded a growth of 6%. ....

Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals Ltd , Glaxosmithkline Pharmaceuticals , Continuing Operations , Managing Director ,

GlaxoSmithKline Pharmaceuticals Ltd Q1FY22 consolidated net profit climbs to Rs. 121.08 crores

GlaxoSmithKline Pharmaceuticals Ltd Q1FY22 consolidated net profit climbs to Rs. 121.08 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals Ltd , Glaxosmithkline Pharmaceuticals , Time Zone , Managing Director , Glaxosmithkline Pharmaceuticals Limited , ஸ்ரீதர் வெங்கடேஷ் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் லிமிடெட் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் , நேரம் ஸோந் , நிர்வகித்தல் இயக்குனர் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் வரையறுக்கப்பட்டவை ,

GSK Pharma skids after Q4 PAT tumbles 90% YoY to Rs 14 cr

Glaxosmithkline Pharmaceuticals fell 1.75% to Rs 1,489.15 after the company s consolidated net profit tanked 89.6% to Rs 14.33 crore on 4.9% increase in net sales to Rs 813.75 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax (PBT) dropped 64.3% to Rs 63.01 crore in Q4 FY21 from Rs 176.55 crore in Q4 FY20. The Q4 result was declared post market hours yesterday, 18 May 2021.
On a standalone basis, revenue for the quarter came in at Rs 807 crore, recording an underlying growth of 6%. Total income came in at Rs 837 crore as compared to Rs 791 crore for the quarter ended 31st March 2020. PBT (before exceptional) for the quarter at Rs 180 crore, recorded a growth of 9%. ....

Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals , Fluarix Tetra , Direct Relief , Capital Market , Healthcare In India , Pharmaceutical Industry In India , Harmaceuticals Nec , Fluarix Tetra , Gsk Pharma , Anti Infectives , Glaxosmithkline Plc , Managing Director , Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals , ஸ்ரீதர் வெங்கடேஷ் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் , நேரடி துயர் நீக்கம் , மூலதனம் சந்தை , சுகாதாரம் இல் இந்தியா ,

GSK Pharma Q4 FY21 Results: GSK Pharma Net Profit Falls 90% To Rs 14 Crore In January-March Quarter

GSK Pharma Q4 FY21 Results: GSK Pharma Net Profit Falls 90% To Rs 14 Crore In January-March Quarter
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.

Sridhar Venkatesh , Glaxosmithkline Pharmaceuticals , Net Profit Falls , March Quarter , ஸ்ரீதர் வெங்கடேஷ் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் , நிகர ப்ராஃபிட் விழும் , அணிவகுப்பு காலாண்டு ,

GSK Pharma posts 6 pc growth in Q4 revenue at Rs 807 crore

GSK Pharma posts 6 pc growth in Q4 revenue at Rs 807 crore
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Sridhar Venkatesh , Glaxosmithkline Plc , Glaxosmithkline Pharmaceuticals , Managing Director Sridhar , Smithkline Pharmaceuticals , ஸ்ரீதர் வெங்கடேஷ் , கிளாக்சோஸ்மித்க்லைன் ப்ல் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் , ஸ்மித்‌க்லைந் மருந்துகள் ,